Patient data, including medical records and patient experiences, are essential for scientists to develop new treatments, especially for rare diseases. The data help identify diagnostic biomarkers, predict disease progression, and help investigators design better clinical trials

The FDA clearance follows European ⁠approval for the test in May. See all topics

Monogram Health Professional Services PC and Monogram Health Inc., collectively known as Monogram Health and headquartered in Tennessee, have agreed to pay $2.4 million to resolve allegations that they violated the False Claims Act by causing the submission of false diagnosis codes to increase payments under the Medicare Advantage program, the Justice Department announced

From why an ASU student-athlete was taken to the hospital to an unusual Mesa burglary involving a man and his 10-year-old son, here’s a look at your top stories on FOX10Phoenix.com for Monday, August 24, 2026

From why an ASU student-athlete was taken to the hospital to an unusual Mesa burglary involving a man and his 10-year-old son, here’s a look at your top stories on FOX10Phoenix.com for Monday, August 24, 2026

SPRING HOUSE, Pa., Aug. 24, 2026 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) today announced the U.S. Food and Drug Administration (FDA) approval of IMAAVY® (nipocalimab-aahu) for the treatment of warm autoimmune hemolytic anemia (wAIHA) – a rare, life-threatening autoantibody disease – in adults and pediatric patients 12 years of age and older currently or previously…